Cargando…

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma

Objective: To investigate the potential biomarkers for venous metastasis of hepatocellular carcinoma (HCC), and briefly discuss their target genes and the signaling pathways they are involved in. Materials and Method: The dataset GSE6857 was downloaded from GEO. Significantly differentially expresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Jia, Rong, Yuan, Luo, Chang-Liang, Li, Shuo, Jiang, Xiang, Weng, Hong, Chen, Hao, Zhang, Wu-Wen, Xie, Wen, Wang, Fu-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287006/ https://www.ncbi.nlm.nih.gov/pubmed/30560088 http://dx.doi.org/10.3389/fonc.2018.00569

Ejemplares similares

Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma
por: Wang, Xicheng, et al.
Publicado: (2019)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

Upregulated hsa_circ_0005785 Facilitates Cell Growth and Metastasis of Hepatocellular Carcinoma Through the miR-578/APRIL Axis
por: Wu, Anqi, et al.
Publicado: (2020)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma
por: Chen, Nan, et al.
Publicado: (2023)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression
por: Cui, Zhongyuan, et al.
Publicado: (2023)

Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2023)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590
por: Wu, Chia-Chang, et al.
Publicado: (2022)

Hsa_circ_0107593 Suppresses the Progression of Cervical Cancer via Sponging hsa-miR-20a-5p/93-5p/106b-5p
por: Liao, Wenyan, et al.
Publicado: (2021)

miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE
por: Chen, Bingqing, et al.
Publicado: (2020)

Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma
por: Wang, Fenglin, et al.
Publicado: (2018)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis
por: WU, Xiaofei
Publicado: (2020)

Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma
por: Ma, Jing, et al.
Publicado: (2019)

Circular RNA hsa_circ_0013958 Functions as an Oncogenic Gene Through Modulating miR-532-3p/WEE1 Axis in Hepatocellular Carcinoma
por: Ma, Tao, et al.
Publicado: (2021)

hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma
por: Anwar, Sumadi Lukman, et al.
Publicado: (2017)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma
por: Wu, Gang, et al.
Publicado: (2015)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors
por: Pasculli, Barbara, et al.
Publicado: (2020)

Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2021)

Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells
por: Zhu, Ying, et al.
Publicado: (2017)

hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration
por: Tan, Shengkui, et al.
Publicado: (2022)

Combined prediction of miR‐210 and miR‐374a for severity and prognosis of hypoxic–ischemic encephalopathy
por: Wang, Zhansheng, et al.
Publicado: (2017)

Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel
por: Pasculli, Barbara, et al.
Publicado: (2019)

HIPK3 Inhibition by Exosomal hsa-miR-101-3p Is Related to Metabolic Reprogramming in Colorectal Cancer
por: Tao, Lihuiping, et al.
Publicado: (2022)

Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma
por: Kim, Hye Seon, et al.
Publicado: (2021)

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma
por: Li, Xi-Zhao, et al.
Publicado: (2021)

Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
por: Zhan, Hao, et al.
Publicado: (2021)

Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis
por: Guan, Xuefeng, et al.
Publicado: (2023)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
por: Li, Jianhao, et al.
Publicado: (2020)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
por: Chedere, Adithya, et al.
Publicado: (2022)

MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis
por: He, Guifang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qt03dh31oeee5g3knca5vbpld9